Laura Azzopardi

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Journal: Neurology
Published: March 06, 2026

Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Journal: JCI insight
Published: May 08, 2019

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 23, 2014

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Journal: Neurology
Published: May 20, 2014

Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.

Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 26, 2013

Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.

Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 28, 2013

The outlook for alemtuzumab in multiple sclerosis.

The outlook for alemtuzumab in multiple sclerosis.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: April 06, 2013

An acquired source of seizures.

An acquired source of seizures.

Journal: BMJ (Clinical research ed.)
Published: May 05, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026